Page 5 - Respiratory Disorder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Escalating Need to Reduce Drug Development Costs and Time to Fuel AI Enabled Drug Discovery & Clinical Trials Market A new study by MarkNtel Advisors, the Global AI Enabled Drug Discovery & Clinical Trials Market is likely to witness around 23.6% CAGR during 2021-26. UNITED SATES, July 29, 2021 /EINPresswire.com/ It owes primarily to the rapidly increasing awareness regarding the benefits of AI among medical professionals, the mounting requirements to minimize the drug discovery cost & time, and burgeoning adoption of cloud-based services & applications, owing to which, faster, efficient, & cost-effective drug discovery, is gaining momentum amongst the pharmaceutical industry stakeholders. Apart from this, delay in patent expiry and expansion of biotechnology industries are other crucial factors likely to enhance the market growth in the years to come.

United statesUnited kingdomSaudi arabiaSouth koreaAsia pacificBiomarker researchMarkntel advisorsGlobal healthcare robotics market researchGlobal imaging modalities market researchComponent softwareCloud pharmaceuticalsContract research organization crosResearch centersProduct developmentK medical imaging market researchAtomwise inc